REMASTer: REcurrent Brain Metastases After SRS Trial

NARecruitingINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

May 10, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

October 31, 2028

Conditions
Brain MetastasesRadiation NecrosisRecurrent TumorRecurrent Metastases
Interventions
PROCEDURE

Radiation Therapy

Post-op hypofractionated therapy or no radiation therapy

DRUG

Steroid Therapy

Best medical management with steroid therapy

PROCEDURE

Laser Interstitial Thermal Therapy

Minimally invasive technique to necrotize intracranial lesions using the NeuroBlate® System (NBS)

Trial Locations (9)

21201

RECRUITING

University of Maryland, Baltimore

27157

RECRUITING

Wake Forest Baptist Medical Center, Winston-Salem

27710

RECRUITING

Duke University Hospital, Durham

44195

RECRUITING

Cleveland Clinic, Cleveland

45429

RECRUITING

Kettering Health, Kettering

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

60637

RECRUITING

University of Chicago, Chicago

63130

RECRUITING

WashU, St Louis

90095

RECRUITING

UCLA, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Monteris Medical

INDUSTRY

NCT05124912 - REMASTer: REcurrent Brain Metastases After SRS Trial | Biotech Hunter | Biotech Hunter